Abstract
Immune-endocrine interactions are important to the regulation of Leydig cell steroidogenesis. We have shown previously that both tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1-β) inhibit 8-bromo-cAMP-(8-Br-cAMP)-stimulated steroidogenesis in mouse Leydig cells. TNF and IL-1 both inhibit cAMP-stimulated testosterone production as well as mRNA and protein levels of cholesterol side chain cleavage enzyme (P450scc) and 17α-hydroxylase/C17,20 lyase (P450c17) in mouse Leydig cells. Neither TNF nor IL-1 affects basal levels of P450scc mRNA and protein. In the present study, we tested the effects of TNF and IL-1 on basal testosterone production and 8-Br-cAMP-stimulated 3β-hydroxysteroid dehydrogenase/Δ5→Δ4 isomerase(3βHSD) expression in Leydig cells. Purified and macrophage-depleted Leydig cells were cultured for 5 d with daily changes of media, and then treated with increasing concentrations of recombinant mouse TNF or IL-1 in the presence or absence of 8-Br-cAMP (50 μM) for 24 h. The media were collected for testosterone RIA and RNA and protein were extracted from cells. Basal testosterone production was inhibited by TNF, but not IL-1. Treatment of Leydig cells with 8-Br-cAMP alone caused a marked increase in 3βHSD mRNA, and protein levels. Both TNF and IL-1 inhibited cAMP-stimulated 3βHSD mRNA and protein levels, but only TNF inhibited basal 3βHSD expression. These results demonstrate that TNF and IL-1 have different effects on basal steroidogenesis in Leydig cells and suggest that TNF-mediated inhibition of basal testosterone production may be owing to the inhibition of basal 3β-HSD expression in Leydig cells.
Similar content being viewed by others
References
Saez, J. M. (1994).Endocr. Rev. 15, 574–626.
Hales, D. B., **ong, Y., and Tur-Kaspa, I. (1992).J. Steroid Biochem. Mol. Biol. 43, 907–914.
**ong, Y. and Hales, D. B. (1993).Endocrinology 133, 2568–2573.
Hayes, R., Chalmers, S. A., Nikolics Paterson, D. J., Atkins, R. C., and Hedger, M. P. (1996).J. Androl. 17, 41–49.
Kern, S., Robertson, S. A., Mau, V. J. and Maddocks, S. (1995).Biol. Reprod. 53, 1407–1416.
Hutson, J. C. (1993),J. Reprod. Immunol. 23, 63–72.
Hales, D. B. (1996). in.The Leydig Cell. Payne, A. H., Hardy M. P., and Russell, L. D. (eds.) Cache River Press Vienna, IL, pp. 451–466.
Hales, D. B. (1992).Endocrinology 131, 2165–2172.
**ong, Y. and Hales, D. B. (1993).Endocrinology 132 2438–2444.
Payne, A. H. and O’Shaughnessy, P. J. (1996). in The Leydig Cell, eds. Payne, A. H., Hardy, M. P., and Russell, L. D. (Cache River Press, Vienna, IL), pp. 259–285.
Akira, S., Hirano, T., Taga, T., and Kishimoto, T. (1990).FASEB J. 4, 2860–2867.
Le, J. and Vilcek, J. (1987).Lab. Invest. 56, 234–248.
Stewart, R. J. and Marsden, P. A. (1995).Am. J. Kidney Dis. 25, 954–966.
Riches, D. W., Chan, E. D., and Winston, B. W. (1996).Immunobiology 195, 477–490.
Dinarello, C. A. (1996).Blood 87, 2095–2147.
Terranova, P. F., and Rice, V. M. (1997).Am. J. Reprod. Immunol. 37, 50–63.
Katz, M. S., Gutierrez, G. E., Mundy, G. R., Hymer, T. K., Caulfield, M. P., and McKee, R. L. (1992).J. Cell Physiol. 153, 206–213.
Johnson, C. L. and Johnson, C. G. (1991).Brain Res. 564, 79–85.
Chen, J. Q., Strom, A., Gustafsson, J. A., and Morgan, E. T. (1995).Mol. Pharmacol. 47, 940–947.
Yamaguchi, M., Koike, K., Yoshimoto, Y., Ikegami, H., Miyake, A., and Tanizawa, O. (1991).Endocrinol. Jpn. 38, 357–361.
Besedovsky, H. O. and Del Rey, A. (1996).Endocr. Rev. 17, 64–102.
Betancur, C., Borrell, J., and Guaza, C. (1995).Neuroendocrinology 62, 47–54.
Naismith, J. H. and Sprang, S. R. (1996).J. Inflam.,47, 1–7.
Fiers, W., Beyaert, R., Boone, E., Cornelis, S., Declercq, W., Decoster, E., et al. (1996).J. Inflamm. 47, 67–75.
Introna, M. and Mantovani, A. (1997).Arterioscler. Thromb. Vasc. Biol. 17, 423–428.
Li, X., Youngblood, G. L., Payne, A. H., and Hales, D. B. (1995).Endocrinology 136, 3519–3526.
Li, X., Held Hales, K., Watanabe, G., Lee, R. J., Pestell, R. G., and Hales, D. B. (1997).Endocrine, in press.
Bankers-Fulbright, J. L., Kalli, K. R., and McKean, D. J. (1996).Life Sci. 59, 61–83.
Pitas, R. E., Innerarity, T., Weinstein, J. N., and Mahley, R. W. (1981).Arteriosclerosis 1, 177–185.
Bensadoun, A. and Weinstein, D. (1976).Anal. Biochem. 70, 241–250.
Laemmli, U. K. (1970).Nature 227, 680–685.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
**ong, Y., Hales, D.B. Differential effects of tumor necrosis factor-α and interleukin-1 on 3β-hydroxysteroid dehydrogenase/Δ5→Δ4 isomeraseexpression in mouse Leydig cells. Endocr 7, 295–301 (1997). https://doi.org/10.1007/BF02801322
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02801322